A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Olivier Chinot, Wolfgang Wick, Warren Mason et al. · New England Journal of Medicine · 2014 · 2.5K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study

Sridharan Gururangan, Susan Chi, Tina Young Poussaint et al. · Journal of Clinical Oncology · 2010 · 194 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 2 trial of single‐agent bevacizumab given in an every‐3‐week schedule for patients with recurrent high‐grade gliomas

Jeffrey J. Raizer, Sean Grimm, Marc C. Chamberlain et al. · Cancer · 2010 · 149 citations · Full text

Medicine, Oncology, Pharmacology +15

A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma

Teri Kreisl, Wei Zhang, Yazmín Odia et al. · Neuro-Oncology · 2011 · 115 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase II Study of Single-agent Bevacizumab in Japanese Patients with Recurrent Malignant Glioma

Motoo Nagane, Ryo Nishikawa, Yusuke Narita et al. · Japanese Journal of Clinical Oncology · 2012 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17